A carregar...
Evaluation of Cladribine treatment in refractory celiac disease type II
AIM: To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) II. METHODS: An open-label cohort-study of RCD II patients treated with 2-CdA was performed between 2000 and 2010. Survival rate, enteropathy associated T-cell lymphoma (EATL) occurrence, clinical...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Co., Limited
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3027018/ https://ncbi.nlm.nih.gov/pubmed/21274381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i4.506 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|